Poll: More Americans Impressed By Media Coverage Of Outbreak Than Trump’s Response

President Donald Trump likes to bash the media’s coverage of the COVID-19 pandemic ad nauseum, but a new Pew poll shows a majority of America isn’t buying what he’s selling.

Continue reading “Poll: More Americans Impressed By Media Coverage Of Outbreak Than Trump’s Response” →

Trade Data Suggest Lack Of Prep For COVID-19: Dem Report

Trade data suggest that U.S. exports of medical supplies surged when the administration should have been preparing for a domestic coronavirus outbreak, according to a new report by Rep. Katie Porter (D-CA).

Continue reading “Trade Data Suggest Lack Of Prep For COVID-19: Dem Report” →

A Company Promised Cheap Ventilators to the Government, Never Delivered and Is Now Charging Quadruple the Price for New Ones

This story first appeared at ProPublica. ProPublica is a Pulitzer Prize-winning investigative newsroom. Sign up for The Big Story newsletter to receive stories like this one in your inbox.

The Dutch company that received millions of taxpayer dollars to develop an affordable ventilator for pandemics, but never delivered them, has struck a much more lucrative deal with the federal government to make 43,000 ventilators at four times the price.

The U.S. Department of Health and Human Services announced Wednesday that it plans to pay Royal Philips N.V. $646.7 million for the new ventilators — paying more than $15,000 each. The first 2,500 units are to arrive before the end of May, HHS said, and the rest by the end of December.

Philips refused to say which model of ventilator the government was buying. But in response to questions from ProPublica, HHS officials said the government is purchasing the Trilogy EV300, the more expensive version of the ventilator that was developed with federal funds.

The deal is a striking departure from the federal contract Philips’ Respironics division signed in September to produce 10,000 ventilators for the Strategic National Stockpile at a cost of $3,280 each.

“This kind of profiteering — paying four times the negotiated price — is not only irresponsible to taxpayers but is particularly offensive when so many people are out of work,” said Dr. Nicole Lurie, who served as the HHS assistant secretary for preparedness and response during the Obama administration. “And besides, most of these ventilators will come too late to make a difference in this pandemic. We’ll then ’replenish’ the stockpile at a ridiculously high price.”

“What else,” she asked, “won’t we be able to buy as a result?”

In an article March 30, ProPublica detailed how the agency’s Biomedical Advanced Research and Development Authority, known as BARDA, had anticipated a decade ago that hospitals would run short of life-saving ventilators in the event of a pandemic. BARDA tried to find a company that could produce an inexpensive, durable ventilator that could be operated by people with minimal training during a crisis. After a deal with one company fell apart, HHS in 2014 agreed to pay Philips $13.8 million to design the stockpile ventilator with an option to purchase 10,000 for $3,280 each. The company won Food and Drug Administration clearance for its Trilogy Evo Universal ventilator in July, and in September HHS put in its order.

But Philips didn’t deliver any ventilators to the stockpile even as the coronavirus spread across the globe and hospitals scrambled for ventilators to keep their patients alive. Rather than making the government-funded design, Philips has been manufacturing more expensive commercial versions of the Trilogy Evo at its Pennsylvania plant and selling them overseas and in the United States.

Philips said it was within its rights to sell the commercial versions first because its contract with HHS gave the company until 2022 to produce the cheaper stockpile version. Philips had only made the stockpile version in small batches and didn’t want to ramp up production on a ventilator that it hadn’t mass produced, a slower process than increasing production of other models, company spokesman Steve Klink explained last month. He also said the government contract did not cover all of the costs for the ventilators’ development.

Now the company won’t have to try. The Philips contract announced Wednesday is for the commercial version, the Trilogy EV300, with the government paying $15,039 each.

The HHS statement said the agency purchased “what was immediately available” under “negotiated pricing” with Philips. President Donald Trump directed HHS Secretary Alex Azar to invoke the Defense Production Act in brokering the deal, the statement said.

The government still expects Philips to produce the 10,000 stockpile versions of the ventilator, but no completion date was given in the statement.

Lurie was in charge of the HHS office that struck the 2014 deal with Philips. During her time, congressional Republicans elected on a Tea Party wave forced cuts in federal spending that hampered efforts to bulk up the stockpile. The goal of the Philips deal, Lurie said, was to produce a low-cost, easy-to-use ventilator and use the stockpile’s budget responsibly. But it was also an effort to show the industry that low-cost ventilators were feasible.

“This was a strategy to reduce health care costs,” Lurie said. “This feels like a conspiracy to keep them high.”

In a news release touting the deal on Wednesday, Philips said that it has been ramping up production and this year has delivered several thousand ventilators to U.S. hospitals — including one in hard-hit New York City. The company, which only makes ventilators in the U.S., said it wanted to continue selling ventilators to other countries in need. Klink declined to comment further.

John Hick, an emergency medicine specialist in Minneapolis who has advised HHS on pandemic response, said it would have been better to have a simpler and cheaper ventilator on hand.

“Don’t get me wrong, I am happy they are getting ventilators,” he said. “If you could buy four times as many for the price, why wouldn’t you do that?”

Hick hopes that federal officials will learn a lesson from the Philips deal.

“We have lost a lot of time,” he said. “It’s kind of like telling someone we are going to hurricane-proof your house after the hurricane has hit.”

Filed under:

 

As Easter Looms, Kansas GOP Lawmakers Overturn Gov’s Order Limiting Church Gatherings

Kansas’ Republican congressional leaders overturned an order issued by the Democratic governor limiting church gatherings of more than 10 people on Wednesday, with Easter just days away.

Continue reading “As Easter Looms, Kansas GOP Lawmakers Overturn Gov’s Order Limiting Church Gatherings” →

Pence Lets Health Experts Appear On CNN After Initially Banning Them

Vice President Mike Pence has walked back its decision to restrict top health experts from appearing on CNN in an effort to pressure the network into airing the daily White House coronavirus task force briefings in full. Continue reading “Pence Lets Health Experts Appear On CNN After Initially Banning Them” →

We Still Don’t Know How Many People Are in the Hospital With COVID-19

This story first appeared at ProPublica. ProPublica is a Pulitzer Prize-winning investigative newsroom. Sign up for The Big Story newsletter to receive stories like this one in your inbox.

Late last month, Vice President Mike Pence sent a letter to administrators of the nation’s 6,000 hospitals requesting a favor.

He asked them to complete a form each day with data on the patients they are treating with COVID-19, the disease caused by the novel coronavirus, and submit it to the Centers for Disease Control and Prevention.

“The data will help us better understand disease patterns and develop policies for prevention and control of health problems related to COVID-19,” Pence wrote.

Now, as COVID-19 nears an apex in some parts of the country, it’s unclear how many hospitals have submitted the requested information. For its part, the CDC has not released the data publicly, saying only that it plans to do so soon.

The U.S. health care system’s response to the coronavirus has exposed many blind spots: the inability to quickly create a test that could be deployed widely, the lack of personal protective equipment for front-line doctors and nurses, and a lack of basic data on hospitalizations to help make informed decisions.

“We’re in a fog because we have so little reliable data,” said Dr. Ashish Jha, director of the Harvard Global Health Institute, which has been studying hospital capacity.

Having real-time data on hospitalizations across the country would do two things. First, it would provide a window into the spread of the coronavirus, albeit a week or so old because of the time it takes for infected patients to get sick enough to be hospitalized. Second, it would enable federal and state officials to identify hot spots that need more equipment and staffing and to shift resources from one region to another.

“You want to avoid what happened in Italy and Spain, where you first find out you have a COVID epidemic when ICUs are filling up,” said Dr. Peter Hotez, co-director of the Center for Vaccine Development at Texas Children’s Hospital and dean of the National School of Tropical Medicine at the Baylor College of Medicine in Houston. “It sounds like in some parts of the [United States], that’s happening because the testing never got up to speed.

“The whole reason you’re doing testing is to get ahead of that.”

As of Wednesday, most states were releasing some information about the patients hospitalized for COVID-19, according to The COVID Tracking Project, which runs a website that tallies key metrics of the national response to the virus. But two states with a high number of cases — Michigan and Texas — were not doing so every day. Among those that are releasing data, the information is not consistent. Some report information on current hospitalizations, which offers a window into whether hospitals can handle the load, while others report information on cumulative hospitalizations, which gives a sense of the disease’s ongoing toll.

What We Know About the Toll of COVID-19

What we are learning, experts say, is that COVID-19 appears to be hitting parts of the United States, particularly New York, in a similar way as it did Wuhan, China. Data from China indicated that approximately one in five patients hospitalized with COVID-19 died. Early data in the United States suggested that far fewer infected people who were hospitalized would die, but that has not held up as more data is reported. In part that’s because seriously ill patients with COVID-19 often spend many days in intensive care before dying.

As of Wednesday night, 80,204 people had confirmed cases of COVID-19 in New York City. Of those, 20,474, or nearly 26%, required hospitalization at some point. All told, 4,260 died, more than 5% of those who have tested positive.

Other cities and regions have not reported data in the same way, so it’s hard to draw comparisons. In California, for instance, 2,714 patients with COVID-19 were hospitalized as of Wednesday, of which 1,154 were in the ICU, more than 42%. Another 3,078 people who were suspected to have COVID-19 were also hospitalized, and 522 of those were in intensive care.

Some states’ data includes many unknowns. Massachusetts, for example, reported that 1,583 of its 16,790 COVID-19 patients required hospitalization, as of Wednesday. Another 4,717 did not. But the state listed the bulk of its cases, 10,490, as being under investigation.

The lack of available data raises questions about the federal government’s $35 billion investment in electronic health records a decade ago, Jha and others say. The shift from paper to digital records was supposed to allow the health care system to be more nimble and provide information more quickly.

“If that’s not happening, that’s a huge failure of the system,” he said.

In Harris County, Texas, which includes Houston, testing had not caught up with the reality in hospital wards. NBC News reported last week that as of March 30, the region around Houston had reported fewer than 950 confirmed coronavirus cases. “But on that same day, there were 996 people hospitalized in the region with confirmed or suspected cases of COVID-19.”

A team at the University of Minnesota’s Carlson School of Management has set out to gather hospitalization information directly from state health departments. In a post Tuesday in the journal Health Affairs, the team noted that there was wide variation between states in the percent of the adult population hospitalized.

In the states that released data on those currently hospitalized, the average hospitalization rate was 11.5 admissions per 100,000 adults, the report said. In Louisiana, the rate was far higher, 49.5 per 100,000 adults.

The report also noted that the average doubling time for cumulative hospitalizations was 4.21 days among the 14 states that reported data daily for at least the last 10 days. The doubling time in Massachusetts was 2.79 days while in Georgia it was 6.08 days. A faster doubling time could mean that there is more community transmission, and therefore, the health care system should be on a higher state of alert.

“While this could in part reflect differences in the timing of the pandemic reaching different states, it could also reflect differences in strategy across states and thus provide a learning opportunity” to understand what regions have done to keep their rates low, the authors wrote.

For its part, the CDC on Friday began releasing a weekly snapshot of hospitalizations, based on data from hospitals that serve about 10% of the U.S. population. It shows that hospitalization rates for COVID-19 in the first few weeks were similar to what is seen at the beginning of the yearly flu season. But given that the impact of COVID-19 has been felt most acutely since the cutoff period for the posted data, it seems certain hospitalization rates have gone up since then.

In a data brief released Wednesday, the CDC provided additional information on COVID-19-confirmed hospitalizations in 14 states from March 1 to 30, based on sites it studies in each state. The per-capita rates were highest in Connecticut, Michigan and New York and much lower in Oregon, Colorado and Ohio, showing the virus has affected different parts of the country differently. (Looking at raw case counts alone doesn’t adjust for differences in state populations.) Older adults had higher hospitalization rates, and most of those hospitalized had underlying health conditions.

As for the initiative announced by Pence, the CDC said it is collecting the daily hospital data through its National Healthcare Safety Network. “The goal of this new module — once up and running — will be to help provide a better picture of what’s happening inside U.S. hospitals during this outbreak. We hope to make this public soon,” a spokeswoman said.

An Ongoing Blind Spot

Even when it comes to cruder forms of data, such as death data, the U.S. system has not proved particularly nimble. During the peak of the opioid epidemic a few years back, it took months and sometimes more than a year to gather accurate information about locations and causes of death, wasting precious time to put in place responses in hotspots, said Dr. Christopher J.L. Murray, director of the Institute for Health Metrics and Evaluation at the University of Washington, whose COVID-19 models have informed the White House response.

“When it comes to hospital data, it’s even less refined” than death data, Murray said. “If we had national daily reporting, inpatient admissions and ICU admissions, that would be a great boost for understanding where the next big wave is coming or where we’re really seeing progress.”

This gap in data is causing problems with efforts to model the disease’s toll. “We’re starting to see this pattern where death reporting goes down on Sunday going into Monday and then they do catch up,” Murray said. “This wreaks havoc on our models.”

State health officials and hospital systems aren’t waiting for good data to increase the number of hospital beds, ICU beds and ventilators available to treat COVID-19 patients.

In Indiana, for example, hospitals had 1,132 ICU beds as of March 1, Indiana Health Commissioner Dr. Kristina Boxin said at a briefing this week. By April 1, that had increased to 2,188 and by April 4, 2,964. “Our hospitals had done such an incredible job of converting every possible room into an ICU room,” she said.

It’s a good thing that happened. As of Sunday, about 58% of the currently available ICU beds across the state were occupied — more than the total available on March 1. Some 924 of the 1,721 occupied ICU beds were taken up by COVID-19 patients.

Dr. Nirav Shah, a senior scholar at Stanford University and the former health commissioner of New York state, said the health care system needs to learn from this crisis to better prepare for the next one, and having accurate, real-time data on hospitalizations is part of that.

“We don’t have the early warning systems we need for this epidemic up and running,” Shah said. “I think everyone understands and this epidemic has made abundantly clear that we need to create systems that are of the 21st century for a 21st-century disease, that we can’t rely on the technology from the ’80s and ’90s that are what power our current survey systems.”

Are you a journalist interested in helping us report on hospitalization numbers in your state? Sign up here.

Filed under:

 

Mnuchin Predicts America Will Be ‘Open For Business’ In May

Treasury Secretary Steve Mnuchin said on Thursday that he believes businesses in the U.S. will be open again as early as next month amid the COVID-19 pandemic.

Continue reading “Mnuchin Predicts America Will Be ‘Open For Business’ In May” →

Fauci Is Cautiously Optimistic About Summer Gatherings Being ‘In The Cards’

Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, offered a ray of hope as more states and cities begin to flatten the curve of COVID-19 cases, during an interview on CBS Thursday morning. Continue reading “Fauci Is Cautiously Optimistic About Summer Gatherings Being ‘In The Cards’” →

Pence Claims Trump Took COVID-19 Threat More Seriously Than World Health Org

In a clear effort to give cover to President Donald Trump, Vice President Mike Pence on Wednesday night accused the World Health Organization (WHO) of mishandling the COVID-19 epidemic when it first began to spread globally.

Continue reading “Pence Claims Trump Took COVID-19 Threat More Seriously Than World Health Org” →